1974
DOI: 10.1007/bf00268573
|View full text |Cite
|
Sign up to set email alerts
|

Economizing DNA-specific labelling by deoxythymidine-5′-monophosphate in Saccharomyces cerevisiae

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
6
0

Year Published

1974
1974
1985
1985

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 33 publications
(6 citation statements)
references
References 12 publications
0
6
0
Order By: Relevance
“…The in vitro activity of thymidylate synthetase from S. cerevisiae requires N5,N'0-methylenetetrahydrofolate (17). Concurrent treatment with aminopterin and sulfanilamide inhibits thymidylate biosynthesis (I3, 15,[21][22][23][24][25], presumably by depleting endogenous tetrahydrofolate pools (Fig. 1).…”
Section: Fig 3 Fdump-induced Expression Of Cycloheximide Resistancementioning
confidence: 99%
See 2 more Smart Citations
“…The in vitro activity of thymidylate synthetase from S. cerevisiae requires N5,N'0-methylenetetrahydrofolate (17). Concurrent treatment with aminopterin and sulfanilamide inhibits thymidylate biosynthesis (I3, 15,[21][22][23][24][25], presumably by depleting endogenous tetrahydrofolate pools (Fig. 1).…”
Section: Fig 3 Fdump-induced Expression Of Cycloheximide Resistancementioning
confidence: 99%
“…Drugs that inhibit this enzyme or that limit the supply of reduced folates can abolish dTMP biosynthesis. In yeast, the combination of aminopterin plus sulfonamide is a potent inhibitor (13,15,(21)(22)(23)(24)(25). Cells thus treated require thymidylate, adenine, histidine, and methionine for growth (13,15 Previous work had shown that dTMP deprivation in yeast was not mutagenic for nuclear genes, but caused mitochondrial point mutations and cytoplasmic petites (14).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…In vivo studies of DNA replication in yeast are limited by the general unsuitability of thymidine as a precursor (15) and, in dTMP uptake or auxotrophic mutants (10,37), by the very slow equilibration of large nucleotide pools (19,24). This problem is avoided with in vitro systems by using deoxynucleoside triphosphate (dNTP) substrates for DNA synthesis.…”
mentioning
confidence: 99%
“…Consequently, yeast DNA has been labeled with other radioactive bases or nucleotides with the attendant problem of incorporation of label into ribonucleic acid. To overcome this problem, mutants have been isolated (1,2,5,6,15,20) after selection for growth when the de novo pathway for deoxythymidine 5'-monophosphate synthesis was blocked through the combined action of aminopterin, an inhibitor ofdihydrofolate reductase, and sulfanilamide, an inhibitor of folate synthesis (1,15,20). The use of these mutants has some drawbacks.…”
mentioning
confidence: 99%